Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SA |
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
2.4B SAR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.6B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Market Distribution
| Min | -6 635.9% |
| 30th Percentile | 1.8% |
| Median | 8.5% |
| 70th Percentile | 15.1% |
| Max | 3 211.1% |
Other Profitability Ratios
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Middle East Pharmaceutical Industries Company SJSC is 21.2%, which is above its 3-year median of 19.8%.
Over the last 2 years, Middle East Pharmaceutical Industries Company SJSC’s Net Margin has increased from 19.5% to 21.2%. During this period, it reached a low of 16.9% on Sep 30, 2024 and a high of 21.6% on Mar 31, 2025.
